Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive Cholangitis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing fecal microbiota transplant to standard treatment for recurrent acute cholangitis. The study is sponsored by Puerta de Hierro Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Puerta de Hierro University Hospital | Conditions: Cholangitis Acute, Recurrence | Phase 2 | Status: NOT_YET_RECRUITING